Back to Authors

Estévez, Álvaro G.

https://orcid.org/0000-0003-2671-3773

Mayo Clinic

Mayo Clinic

Citations 1

Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease
Trushina, Eugenia , Heldebrant, Michael P., Pérez-Terzic, Carmen, Bortolon, Ryan, Kovtun, Irina V. , Badger, John D., Estévez, Álvaro G. , Windebank, Anthony J. , Dyer, Roy B. , Yao, Janet , McMurray, Cynthia T. , Terzic, André , Trushina, Eugenia

Proceedings of the National Academy of Sciences | October 14, 2003 | Volume: 100 | Issue: 21 | Pages: 12171-12176

10.1073/pnas.2034961100 Get It

There has been a longstanding debate regarding the role of proteolysis in Huntington's disease. The toxic peptide theory posits that N-terminal cleavage fragments of mutant Huntington's disease protein [mutant huntingtin (mhtt)] enter the nucleus to cause transcriptional dysfunction. However, recent data suggest a second model in which proteolysis of full-length mhtt is inhibited. Importantly, the two competing theories differ with respect to subcellular distribution of mhtt at initiation of toxicity: nuclear if cleaved and cytoplasmic in the absence of cleavage. Using quantitative single-cell analysis and time-lapse imaging, we show here that transcriptional dysfunction is “downstream” of cytoplasmic dysfunction. Primary and reversible toxic events involve destabilization of microtubules mediated by full-length mhtt before cleavage. Restoration of microtubule structure by taxol inhibits nuclear entry and increases cell survival.